Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Friday 01 April, 2016

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 9532T
GlaxoSmithKline PLC
01 April 2016

GlaxoSmithKline plc


Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons



In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc (GSK) was advised on 1 April 2016 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 31 March 2016, at a price of $40.55 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401(K) plan:




Connected Person


Number of ADSs


Dr K Slaoui (Connected Person of Dr M M Slaoui)







V A Whyte

Company Secretary


1 April 2016


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t